In August 2024, the Swedish market has shown resilience amid global economic uncertainties, with indices displaying moderate fluctuations. As investors navigate this volatile landscape, identifying growth companies with high insider ownership can offer a measure of confidence and alignment of interests between company executives and shareholders.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.8% | 73.8% |
Yubico (OM:YUBICO) | 37.5% | 43.8% |
BioArctic (OM:BIOA B) | 34% | 102.1% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
InCoax Networks (OM:INCOAX) | 18.1% | 104.9% |
Calliditas Therapeutics (OM:CALTX) | 12.7% | 54.9% |
SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
edyoutec (NGM:EDYOU) | 13.4% | 63.1% |
Below we spotlight a couple of our favorites from our exclusive screener.
EQT (OM:EQT)
Simply Wall St Growth Rating: ★★★★★☆
Overview: EQT AB (publ) is a global private equity firm specializing in private capital and real asset segments, with a market cap of SEK376.02 billion.
Operations: The company's revenue segments include Central (€37.20 million), Real Assets (€878.70 million), and Private Capital (€1.28 billion).
Insider Ownership: 31%
Return On Equity Forecast: 23% (2027 estimate)
EQT AB has demonstrated strong growth, with earnings increasing by 384.2% over the past year and forecasted to grow 56.8% annually, outpacing the Swedish market's 15.7%. The company's high insider ownership aligns with its strategic M&A activities, including potential bids for Compass Education and Aavas Financiers. Despite some insider selling, EQT's revenue is expected to grow significantly at 17.9% per year, reinforcing its position as a growth company with substantial insider involvement in Sweden.
- Delve into the full analysis future growth report here for a deeper understanding of EQT.
- The valuation report we've compiled suggests that EQT's current price could be inflated.
AB Sagax (OM:SAGA A)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AB Sagax (publ) is a property company operating in Sweden, Finland, France, Benelux, Spain, Germany, and other European countries with a market cap of SEK94.55 billion.
Operations: The company generates revenue primarily from its Real Estate - Rental segment, amounting to SEK4.63 billion.
Insider Ownership: 28.6%
Return On Equity Forecast: N/A (2027 estimate)
AB Sagax has shown impressive growth, with earnings rising 196.5% over the past year and forecasted to grow 30.73% annually, outpacing the Swedish market's 15.7%. Recent earnings guidance expects profit from property management to reach SEK 4.3 billion in 2024. Despite some shareholder dilution, insider ownership remains substantial, aligning with strategic moves like a €500 million green bond issuance for corporate purposes under its Green Finance Framework.
- Click to explore a detailed breakdown of our findings in AB Sagax's earnings growth report.
- Our comprehensive valuation report raises the possibility that AB Sagax is priced higher than what may be justified by its financials.
Sectra (OM:SECT B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sectra AB (publ) provides medical IT and cybersecurity solutions across Sweden, the United Kingdom, the Netherlands, and Europe, with a market cap of SEK46.82 billion.
Operations: Sectra's revenue segments include Imaging IT Solutions at SEK2.55 billion, Secure Communications at SEK367.35 million, and Business Innovation at SEK89.87 million.
Insider Ownership: 30.3%
Return On Equity Forecast: 30% (2027 estimate)
Sectra AB exhibits strong growth potential with earnings forecasted to grow annually by 19.3%, outpacing the Swedish market. Recent financials show a revenue increase to SEK 3.04 billion for the fiscal year, reflecting robust performance. Key developments include successful implementation of Sectra One Cloud in Belgian hospitals and the launch of a genomics IT module in collaboration with the University of Pennsylvania Health System, enhancing its enterprise imaging solutions and expanding its market presence.
- Click here and access our complete growth analysis report to understand the dynamics of Sectra.
- Our valuation report here indicates Sectra may be overvalued.
Summing It All Up
- Reveal the 88 hidden gems among our Fast Growing Swedish Companies With High Insider Ownership screener with a single click here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if EQT might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com